Literature DB >> 22956489

The role of activation-induced deaminase in antibody diversification and genomic instability.

Jing H Wang1.   

Abstract

More than a decade ago, activation-induced deaminase (AID) was identified as the initiator for somatic hypermutation (SHM) and class switch recombination (CSR). Since then, tremendous progress has been achieved toward elucidating how AID functions. AID targets the highly repetitive switch regions of the immunoglobulin heavy chain (IgH) locus to induce DNA double-strand breaks (DSBs), which can be rejoined, leading to switch of constant regions of antibody. When targeting to variable region exons of IgH and IgL loci, AID predominantly induces point mutations, termed SHM, resulting in increased affinity of antibody for antigen. While SHM and CSR enhance antibody diversity, AID-initiated DSBs and mutations may predispose B cells to carcinogenesis. This review focuses on the mechanisms that provide the specificity of AID targeting to Ig loci and the role of AID in genomic instability.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22956489     DOI: 10.1007/s12026-012-8369-4

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  163 in total

Review 1.  Towards an understanding of somatic hypermutation.

Authors:  H Jacobs; L Bross
Journal:  Curr Opin Immunol       Date:  2001-04       Impact factor: 7.486

2.  Somatic mutation hotspots correlate with DNA polymerase eta error spectrum.

Authors:  I B Rogozin; Y I Pavlov; K Bebenek; T Matsuda; T A Kunkel
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

3.  Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice.

Authors:  Cristina Rada; Gareth T Williams; Hilde Nilsen; Deborah E Barnes; Tomas Lindahl; Michael S Neuberger
Journal:  Curr Biol       Date:  2002-10-15       Impact factor: 10.834

Review 4.  AID targeting in antibody diversity.

Authors:  Rushad Pavri; Michel C Nussenzweig
Journal:  Adv Immunol       Date:  2011       Impact factor: 3.543

5.  Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.

Authors:  Almudena R Ramiro; Mila Jankovic; Elsa Callen; Simone Difilippantonio; Hua-Tang Chen; Kevin M McBride; Thomas R Eisenreich; Junjie Chen; Ross A Dickins; Scott W Lowe; Andre Nussenzweig; Michel C Nussenzweig
Journal:  Nature       Date:  2006-01-08       Impact factor: 49.962

6.  Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70.

Authors:  Cristian Boboila; Mila Jankovic; Catherine T Yan; Jing H Wang; Duane R Wesemann; Tingting Zhang; Alex Fazeli; Lauren Feldman; Andre Nussenzweig; Michel Nussenzweig; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

7.  S region sequence, RNA polymerase II, and histone modifications create chromatin accessibility during class switch recombination.

Authors:  Lili Wang; Robert Wuerffel; Scott Feldman; Ahmed Amine Khamlichi; Amy L Kenter
Journal:  J Exp Med       Date:  2009-07-13       Impact factor: 14.307

8.  AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line.

Authors:  Ahmad Faili; Said Aoufouchi; Quentin Guéranger; Carole Zober; Anne Léon; Barbara Bertocci; Jean-Claude Weill; Claude-Agnès Reynaud
Journal:  Nat Immunol       Date:  2002-07-29       Impact factor: 25.606

9.  Two levels of protection for the B cell genome during somatic hypermutation.

Authors:  Man Liu; Jamie L Duke; Daniel J Richter; Carola G Vinuesa; Christopher C Goodnow; Steven H Kleinstein; David G Schatz
Journal:  Nature       Date:  2008-02-14       Impact factor: 49.962

Review 10.  A coming-of-age story: activation-induced cytidine deaminase turns 10.

Authors:  Rebecca K Delker; Sebastian D Fugmann; F Nina Papavasiliou
Journal:  Nat Immunol       Date:  2009-10-20       Impact factor: 25.606

View more
  10 in total

Review 1.  DNA modifications and neurological disorders.

Authors:  Yi-Lan Weng; Ran An; Jaehoon Shin; Hongjun Song; Guo-li Ming
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

2.  AID-initiated DNA lesions are differentially processed in distinct B cell populations.

Authors:  Zhangguo Chen; Sheila Ranganath; Sawanee S Viboolsittiseri; Maxwell D Eder; Xiaomi Chen; Mihret T Elos; Shunzong Yuan; Shunzhong Yuan; Erica Hansen; Jing H Wang
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

Review 3.  Generation and repair of AID-initiated DNA lesions in B lymphocytes.

Authors:  Zhangguo Chen; Jing H Wang
Journal:  Front Med       Date:  2014-04-21       Impact factor: 4.592

4.  TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 Activation.

Authors:  Rachel A Woolaver; Xiaoguang Wang; Yonatan Dollin; Ping Xie; Jing H Wang; Zhangguo Chen
Journal:  J Immunol       Date:  2018-10-19       Impact factor: 5.422

5.  Imbalanced PTEN and PI3K Signaling Impairs Class Switch Recombination.

Authors:  Zhangguo Chen; Andrew Getahun; Xiaomi Chen; Yonatan Dollin; John C Cambier; Jing H Wang
Journal:  J Immunol       Date:  2015-10-23       Impact factor: 5.422

Review 6.  TET proteins: on the frenetic hunt for new cytosine modifications.

Authors:  Benjamin Delatte; François Fuks
Journal:  Brief Funct Genomics       Date:  2013-04-26       Impact factor: 4.241

7.  Unexpected effects of different genetic backgrounds on identification of genomic rearrangements via whole-genome next generation sequencing.

Authors:  Zhangguo Chen; Katherine Gowan; Sonia M Leach; Sawanee S Viboolsittiseri; Ameet K Mishra; Tanya Kadoishi; Katrina Diener; Bifeng Gao; Kenneth Jones; Jing H Wang
Journal:  BMC Genomics       Date:  2016-10-21       Impact factor: 3.969

Review 8.  HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma.

Authors:  Xiaoguang Wang; Brittany C Waschke; Rachel A Woolaver; Samantha M Y Chen; Zhangguo Chen; Jing H Wang
Journal:  Protein Cell       Date:  2020-03-11       Impact factor: 14.870

Review 9.  Detection of Genomic Uracil Patterns.

Authors:  Angéla Békési; Eszter Holub; Hajnalka Laura Pálinkás; Beáta G Vértessy
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 10.  Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.

Authors:  Xiaoyu Wang; Yumin Xia
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.